Abstract
Melanoma risk prediction tools have been developed to assist with estimating a person’s risk of developing a primary melanoma, yet their integration into clinical practice and their influence on decision making remains poorly understood. Using a mixed-methods approach, we aimed to evaluate the use of two online melanoma risk prediction tools – one for estimating risk of a first primary melanoma and the other for estimating risk of a subsequent primary melanoma – by clinicians in Australia. We found that the first primary and subsequent primary melanoma risk prediction tools were accepted by clinicians for use in routine practice; however, variability in their use and challenges in interpreting and applying risk results may hinder their full potential.
Funding Information
  • National Health and Medical Research Council (#2008454)
  • National Health and Medical Research Council (#2009923)
  • a Daffodil Centre Postgraduate Student Scholarship
  • Melanoma Institute Australia (2022/CDF1154)
  • a NHMRC Investigator (2022/GNT2018514)
  • a NHMRC Investigator (#2007839)
  • University of Sydney

This publication has 7 references indexed in Scilit: